In risk we trust/Editing embryos and mirroring future risks and uncertainties

Medicine, Health Care, and Philosophy
Eva Šlesingerová

Abstract

Tendencies and efforts have shifted from genome description, DNA mapping, and DNA sequencing to active and profound re-programming, repairing life on genetic and molecular levels in some parts of contemporary life science research. Mirroring and materializing this atmosphere, various life engineering technologies have been used and established in many areas of life sciences in the last decades. A contemporary progressive example of one such technology is DNA editing. Novel developments related to reproductive technologies, particularly embryo editing, prenatal human life engineering, and germline engineering need to be analyzed against the broader social and structural background. The crucial analytical scope for this paper is a specific field: the life-editing technologies used in reproductive medicine and performed experimentally on viable human embryos, particularly CRISPR/Cas9 technology. This text argues that germline editing technologies, as a representative part of contemporary biomedicine, are merging ideas of treatment and enhancement to avoid future risks. Using this specific life manipulation of embryos and gametes, the text analyzes these processes within the concept of power over life-biopower and the specific gove...Continue Reading

References

Mar 2, 2002·Science·Marie E Csete, John C Doyle
Apr 29, 2009·Sociology of Health & Illness·Aviad E Raz
Jul 25, 2009·Medicine, Health Care, and Philosophy·Leen TrommelmansKris Dierickx
Apr 14, 2011·Studies in History and Philosophy of Biological and Biomedical Sciences·Jane Calvert, Joan H Fujimura
Oct 5, 2011·Medicine, Health Care, and Philosophy·Hub Zwart
Dec 20, 2011·Croatian Medical Journal·Tora HolmbergAndrew Webster
Oct 27, 2012·Croatian Medical Journal·Bettina Bock von Wulfingen
Feb 7, 2013·ELife·Martin JinekJennifer Doudna
Sep 5, 2014·Medicine, Health Care, and Philosophy·Patrick Heavey
Apr 10, 2016·Archives of Disease in Childhood. Education and Practice Edition·Melody RedmanDavid King
Mar 24, 2017·British Medical Bulletin·John J MulvihillUNKNOWN International Human Genome Organisation (HUGO) Committee of Ethics, Law, and Society (CELS)
Jul 21, 2017·Medicine, Health Care, and Philosophy·Giulia Cavaliere

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Courtney Addison, Samuel Taylor-Alexander
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society
Bin He
[Rinshō ketsueki] The Japanese journal of clinical hematology
Takashi Yamamoto, Naoaki Sakamoto
© 2022 Meta ULC. All rights reserved